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Abstract 
The time patients wait before seeking help for cancer symptoms is among the most 
important factors contributing to diagnostic delays in cancer. We reviewed the 
association between time to help-seeking and three psychological factors: symptom 
knowledge, symptom interpretation, and beliefs about cancer (Prospero review protocol 
CRD42018088944). Forty-seven studies published between 1990 and 2019 met the 
inclusion criteria, providing data on 44,961 participants from 22 countries concerning 
seven cancer sites. A series of random-effects meta-analyses and meta-regressions were 
conducted. Better symptom knowledge was related to lower odds of a long help-seeking 
interval in both studies with healthy populations (OR=.73, 95% CI [.63, .84], k=19) and 
with patients (OR=.40, 95% CI [.23, .69], k=12), and so was interpreting experienced 
symptoms as cancer-related (OR=.52, 95% CI [.36, .75], k=13 studies with patients). 
More positive beliefs about cancer (i.e., that cancer is treatable) were associated with 
lower odds of a long help-seeking interval in both studies with healthy populations 
(OR=.70, 95% CI [.52, .92], k=11) and with patients (OR=.51, 95% CI [.32, .82], k=7). 
Symptom knowledge, interpretation, and beliefs about cancer are likely to be universal 
predictors of help-seeking. Theoretical models of patient help-seeking and interventions 
aiming to reduce delays should incorporate these factors.  
Keywords: cancer; patient interval; time to help-seeking; diagnostic delay; beliefs; 
symptoms; knowledge 
  
Psychological factors related to time to help-seeking for cancer symptoms: 
A meta-analysis across cancer sites  
Delays in the diagnosis of cancer have been associated with less favourable 
patient outcomes across several types of cancer including breast, colorectal, head and 
neck, melanoma, and testicular cancer (Neal et al., 2015). Delays may occur at different 
stages of the diagnostic process generally referred to as the patient interval (the time 
from symptom onset to help-seeking, i.e., first consultation) and the diagnostic interval 
(the time from first consultation to diagnosis) (Walter, Webster, Scott, & Emery, 2012). 
Research shows that patient intervals could be two-to-five-fold longer than diagnostic 
intervals across multiple types of cancer (Allgar & Neal, 2005; Lyratzopoulos et al., 
2015). This suggests that there is great potential to achieve earlier diagnosis and better 
outcomes for symptomatic cancers by reducing the patient interval. This can be 
achieved by individual interventions or large-scale information campaigns that address 
drivers of delayed help-seeking (Austoker et al., 2009; Power & Wardle, 2015). 
However, up to date there is limited evidence that such campaigns can successfully 
shorten help-seeking intervals and improve cancer outcomes (Austoker et al., 2009; 
Bankhead, 2017). 
 To understand the causes for long patient intervals and design effective 
interventions, researchers have studied how several psychological factors affect patient 
help-seeking. Reducing time to help-seeking by targeting psychological factors could be 
especially effective among lower socio-economic groups who are more likely to report 
psychological barriers, have low symptom knowledge, and present later to a health-care 
professional (McCutchan, Wood, Edwards, Richards, & Brain, 2015).  Factors such as 
knowledge and interpretation of symptoms and beliefs regarding the curability or 
fatality of cancer have been suggested to influence the patient interval (McCutchan et 
al., 2015; Smith, Pope, & Botha, 2005). For instance, better symptom knowledge has 
been related to shorter patient intervals in breast (Harirchi, Ghaemmaghami, Karbakhsh, 
Moghimi, & Mazaherie, 2005; Hunter, Grunfeld, & Ramirez, 2003; Mirfarhadi, 
Ghanbari, Khalili, & Rahimi, 2017), cervical (Ouasmani et al., 2016), lung (Desalu et 
al., 2016), and skin cancer (Oliveria et al., 1999). Similarly, attributing experienced 
symptoms to cancer has been related to shorter patient intervals in colorectal (Jensen, 
Hvidberg, Pedersen, Aro, & Vedsted, 2016; Simons et al., 2017), breast (Burgess, 
Ramirez, Richards, & Love, 1998), and head and neck cancers (Akram, Ali Siddiqui, & 
Masroor Karimi, 2014; Vaisanen et al., 2014). However, not all studies have shown 
consistent results (Grunfeld & Kohli, 2010; Hashim et al., 2011; Pedersen, Hansen, & 
Vedsted, 2013; Scott et al., 2008; Scott, McGurk, & Grunfeld, 2008; Smits, Boivin, 
Menon, & Brain, 2017; van Osch, Lechner, Reubsaet, de Nooijer, & de Vries, 2007).  
More positive beliefs about cancer (e.g., that cancer is a treatable disease), have 
also been related to shorter patient intervals in colorectal (Jensen et al., 2016; Pedersen 
et al., 2018) and lung cancer (Pedersen et al., 2018). Unfortunately, recent research 
showed that about 25% of participants from six different countries (UK, Australia, 
Canada, Denmark, Norway, and Sweden) think that a cancer diagnosis is a death 
sentence (Pedersen et al., 2018), a belief that does not correspond to many recent 
improvements in cancer treatment and survival. However, not all studies find a 
relationship between beliefs and the patient interval (Brain et al., 2014; Grunfeld & 
Kohli, 2010; Harirchi et al., 2005; Pedersen et al., 2018; van Osch et al., 2007). 
The recognition and interpretation of symptoms as cancer-related and beliefs 
about the treatability of cancer are important components of several health behaviour 
models used to understand patient help-seeking. For instance, the Judgment to Delay 
Model (Facione, Miaskowski, Dodd, & Paul, 2002) and the Grounded Model of Breast 
Cancer Delay (Unger-Saldana & Infante-Castaneda, 2011) are theories developed in the 
context of patient help-seeking for cancer symptoms. Both theories consider symptom 
knowledge, symptom interpretation, and beliefs about the treatability of cancer as 
important precursors to help-seeking. Another more general model that has been 
frequently applied to the context of help-seeking for cancer symptoms is the Model of 
Illness Representation (also referred to as the Common Sense or Self-Regulation 
Model) (Hunter et al., 2003; Leventhal, 1984; O'mahony & Hegarty, 2009). According 
to this model, people construct cognitive representations of a disease in order to 
understand it and cope with it. These cognitive representations form five dimensions, 
two of which consider the recognition and interpretation of symptoms (identity) and the 
extent to which the person believes that the disease can be cured (cure/control).  
More general models such as the Health Belief Model (Rosenstock, Strecher, & 
Becker, 1988) and the Theory of Planned Behaviour (Ajzen & Madden, 1986) have also 
been applied to the context of help-seeking. However, these models were developed to 
address prevention and behaviour change and their suitability for help-seeking due to 
symptoms has been questioned (O'mahony & Hegarty, 2009). The Health Belief Model 
has been frequently used as a basis for interventions to improve cancer awareness and 
early presentation (Austoker et al., 2009). Within this model, perceived susceptibility 
(influenced by symptom recognition and interpretation) and perceived severity 
(influenced by beliefs about the treatability of cancer) motivates individuals to reduce 
the perceived threat of the disease by taking relevant action (i.e., help-seeking).  
Perceived susceptibility and severity could also motivate action by influencing attitudes 
towards help-seeking. Specifically, the Theory of Planned Behaviour considers attitudes 
and social norms as main determinants of behaviour (Ajzen & Madden, 1986).  
The high theoretical relevance of the three psychological factors reviewed 
above, together with the accumulated number of studies showing mixed results, indicate 
the need for a systematic synthesis of the evidence. The cancer-site focus of previous 
reviews and the heterogeneity of study designs and measurement constructs have so far 
precluded meta-analyses in the context of help-seeking for cancer symptoms 
(McCutchan et al., 2015). However, the three factors of interest for the current research 
are frequently measured in diverse studies suggesting they may be universal factors of 
interest across most cancers. A quantitative synthesis of the literature with respect to 
such factors would help estimate the strength of relationships and explain the existing 
heterogeneity by testing potential moderators such as study and sample characteristics. 
This could reveal the reasons for inconsistent findings and potentially pinpoint to what 
extent and under what conditions it may be effective to target different psychological 
factors.  
 In sum, we conducted a meta-analysis of the relationship between the patient 
interval and symptom knowledge, symptom interpretation, and beliefs about cancer. 
These factors are potentially universal (i.e., could be important regardless of the health 
system or cancer site), actionable (i.e., can be addressed by individual or community 
campaigns), and considered by various health behaviour theories as determinants of 
help-seeking for cancer symptoms. A preliminary review indicated that these factors are 
among the most frequently reported across studies of different cancer sites and 
definitions and measures are relatively homogenous, thus a meta-analytic synthesis of 
the literature would be feasible and meaningful. 
Methods 
Pre-selection of psychological factors for meta-analysis. Several 
methodological requirements must be met for meta-analysis to be meaningful. These 
include having enough studies to reliably estimate an effect size and ideally investigate 
potential moderators, and sufficient homogeneity between study measures. To identify 
psychological factors meeting such requirements we conducted a preliminary literature 
study of the results of several existing systematic reviews, following Kummer, Walter, 
Chilcot, and Scott (2017). These included the most recent broad-scope systematic 
review of factors related to help-seeking for cancer symptoms across diverse cancer 
sites (McCutchan et al., 2015), complemented with several other recent reviews 
(Balasooriya-Smeekens, Walter, & Scott, 2015; Dubayova et al., 2010; Kummer et al., 
2017; Macleod, Mitchell, Burgess, Macdonald, & Ramirez, 2009; Webber, Jiang, 
Grunfeld, & Groome, 2017). We aimed to identify factors: a) that are psychological, 
i.e., related to patients’ perceptions, interpretations, feelings, or cognitions, b) that are 
frequently measured in quantitative studies in relation to help-seeking (i.e.,, preliminary 
identification of at least about 10 studies), c) whose definitions and measures are 
relatively homogenous, and d) that were not covered by a recent meta-analysis (or an 
attempt to perform one). Symptom knowledge, symptom interpretation (as cancer vs. 
other), and beliefs about cancer (i.e., specifically the positive-negative dimension 
regarding perceived treatability/survivability) met these conditions. Negative emotions 
such as fear or worry were also frequently cited but were covered by a recent review 
which determined meta-analysis not to be feasible at this point (Balasooriya-Smeekens 
et al., 2015). 
Literature search. To conduct the three meta-analyses we followed the 
PRISMA guidelines for conducting and reporting systematic reviews (Moher, Liberati, 
Tetzlaff, Altman, & Prisma Group, 2009). We searched the following databases: 
Medline (PubMed), PsychINFO, Web of Science, and Scopus, and considered articles 
published from 1990 until April 2019 when the search was conducted. The search terms 
used are provided in the pre-registration protocol on PROSPERO [CRD42018088944]: 
tinyurl.com/PatientIntervalR and on the Open Science Framework: osf.io/95cvf/. The 
list of terms was constructed based on a preliminary review of the literature and the 
search terms of a recent review of broader scope (McCutchan et al., 2015), and was 
further expanded after feedback from reviewers.  
Selection criteria. We considered quantitative studies with adult participants, 
including all cancer sites, without restrictions regarding study type. In particular, we 
considered observational studies that were a) actual symptom presentation studies, i.e., 
studies with cancer patients or symptomatic patients undergoing investigation for 
cancer reporting retrospectively how long they waited before seeking help, and b) 
anticipated symptom presentation studies, i.e., hypothetical cross-sectional studies with 
healthy populations reporting how long they would wait before seeking help. We 
included studies reporting the relationship between the patient interval and a) symptom 
knowledge, b) symptom interpretation as related to cancer, or c) beliefs about the 
survivability/treatability of cancer. Patient interval was defined as the time in days, 
weeks or months elapsed between the start of symptoms and the first (actual or 
hypothetical) medical consultation (Weller et al., 2012). Symptom knowledge referred 
to the knowledge or recognition of cancer symptoms or warning signs. Symptom 
interpretation referred to attributing experienced symptoms possibly to cancer or 
thinking that it could be cancer at some point. Beliefs about cancer referred to beliefs 
that the participant holds regarding the curability or survivability of cancer, the 
effectiveness of modern cancer treatments, or the benefits of early diagnosis or 
treatment. There were no restrictions regarding language. Reviews, qualitative studies, 
editorials, case reports, and conference abstracts were excluded.  
The titles of all studies retrieved were screened by one author who discarded 
studies if it was clear from the title that they would not meet the inclusion criteria (e.g., 
systematic reviews or a topic irrelevant to the search). The abstracts of the selected titles 
were screened for eligibility independently by two researchers; disagreements were 
resolved through discussion or review of the full text. The full texts of the selected 
abstracts were reviewed for eligibility by two authors; disagreements were resolved 
through discussion. Additional search was conducted of the reference lists of the 
selected studies and the same procedure was followed with the additionally identified 
titles. Study authors were contacted to provide additional information where needed. 
Data extraction. One researcher extracted data from the studies using 
predefined data fields according to the review protocol and another author checked it 
thoroughly. Disagreements were resolved through discussion. We extracted basic 
information about the study, demographic information about participants, a brief 
description of the study sample (see Table 1), and information regarding several 
candidate moderators of the studied effects (see below). We also recorded the types of 
scales used to assess the constructs of interest, their interpretation, and the statistical 
result reported. 
Because the resulting sample of studies was highly international, in addition to 
the pre-defined list of candidate moderators in the protocol, we extracted several socio-
economic country-level indicators that could explain heterogeneity in the observed 
effects. We considered the country where each study was conducted and extracted the 
corresponding Human Development Index (HDI), GINI coefficient, and health 
expenditure in thousands of $USD three years before the article’s date of publication 
(e.g., for 2000 for a study published in 2003) or for the nearest year when data were not 
available. Data were obtained from the data bank of the World Bank 
(http://databank.worldbank.org). The HDI is a summary measure of average 
achievement in key dimensions of human development including a long and healthy 
life, being knowledgeable (e.g., mean years of schooling), and having a decent standard 
of living (Malik, 2013). The GINI coefficient is a measure of the country’s income 
inequality (0=perfect equality to 100=perfect inequality). Health expenditure was 
computed based on the country’s GDP and the percentage of GDP dedicated to public 
health expenditure. 
Risk of bias assessment. The risk of bias for each study was assessed with the 
NIH Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies 
checklist (National Institutes of Health, 2014), which is suitable for cross-sectional 
descriptive studies. The scale was adapted by dropping five items applicable to cohort 
studies (e.g., loss to follow up, exposure measured prior to outcome). In addition, three 
items assessing the quality of the patient interval measurement were added from the 
Aarhus statement checklist (Weller et al., 2012). These items referred to a) the timing of 
the interview in relation to the date of diagnosis, b) triangulation of self-reported data 
with other sources, and c) treatment of the patient interval in analysis. Items a) and b) 
apply only to studies with patients already diagnosed with cancer; other types of studies 
received a score of 1 for these items as they are not susceptible to such biases. Thus, the 
maximum possible score on the quality assessment was 12 (9 NIH items + 3 Aarhus 
items). We used this score in analyses and for descriptive purposes considered a score 
higher than 80% (10 or more) as low risk of bias, a score of 60% to 80% (>7 and <10) 
as medium risk, and a score lower than 60% (≤7) as high risk. These cut-offs were 
arbitrary and a broader range of scores was considered as high risk given the low 
evidence category of the studies (cross-sectional). Studies were assessed independently 
by two researchers and disagreements were resolved through discussion. 
Statistical analysis. The majority of studies (35, 72%) analyzed the patient 
interval by dichotomizing it into “delay” vs. “no delay” groups, and the most frequently 
reported effect size measure was the odds ratio (OR): for one unit change in the 
symptom knowledge score (reflecting the knowledge of one additional symptom), for 
attributing a symptom to cancer vs. to other causes, and for one unit change in the 
cancer belief scale used. Effect sizes that were not originally ORs were transformed to 
ORs with the associated 95% confidence intervals (CI) using formulae for effect size 
transformation (e.g., to transform standardized mean differences into ORs (da Costa et 
al., 2012; Hozo, Djulbegovic, & Hozo, 2005; Peterson & Brown, 2005; Polanin & 
Snilstveit, 2016; Rodríguez-Barranco, Tobías, Redondo, Molina-Portillo, & Sánchez, 
2017). The implications of these transformations were examined in sensitivity analysis 
(see below).  
Some studies (Ouasmani et al., 2016; Pedersen et al., 2018; Quaife et al., 2014) 
reported more than one effect size for a particular relationship of interest in the same 
sample of participants (based on separate analyses for several cancer symptoms). 
Because of the assumption of independence of meta-analysis, only one effect size can 
be considered per study sample for a given relationship; thus, we estimated an average 
effect size across cancer symptoms whereby effect sizes were weighed by the inverse of 
the sampling variances (Viechtbauer, 2010). 
Analyses were conducted in R using the package metaphor (Viechtbauer, 2010). 
Meta-analyses were conducted using logORs and studies were weighed by their 
precision using standard errors (Viechtbauer, 2010). Random-effects models were fitted 
because substantial heterogeneity between studies was expected. Confidence intervals 
(95%) excluding 0 were considered as significant and the I2 statistic was used as a 
measure of heterogeneity. Models were estimated separately for studies with healthy 
populations and studies with patients. We tested the following candidate moderators: 
definition of delay, risk of bias score, effect based on adjusted vs. unadjusted (for other 
covariates) analysis, gender composition of the sample (female vs. mixed), and use of 
theoretical model vs. not. Definition of delay was expressed in weeks and referred to the 
scale used to measure the patient interval (e.g., when a study divided the sample into 
“delay” and “no delay” groups based on the cut-off of one month, the value of the 
variable was 4 weeks). The moderators were tested one at a time due to the limited 
number of studies. An OR<1 for the effect of a moderator means that the 
presence/higher value of the moderator is associated with a stronger effect; an OR>1 for 
the effect of a moderator means that the presence/higher value of the moderator is 
associated with a weaker effect. Because of the low frequency of studies on separate 
cancer sites per-site synthesis was not meaningful; however, data are grouped according 
to cancer site in figures and are openly available for researchers interested in specific 
locations (on the Open Science Framework: osf.io/95cvf/).  
Sensitivity analyses involved i) effect size estimation excluding studies that were 
outliers (based on standardized residuals and influential case diagnostics using Cook’s 
distances, (Viechtbauer, 2010)), ii) excluding studies with high risk of bias, and iii) 
comparing effect sizes between studies where those were transformed from other 
measures (not original ORs) to those where effect sizes were originally ORs (Polanin & 
Snilstveit, 2016). The possibility of publication bias was examined using i) contour 
enhanced funnel plots that can differentiate asymmetry due to publication bias from that 
due to other factors (Peters, Sutton, Jones, Abrams, & Rushton, 2008) and ii) Beg and 
Egger statistical tests (Viechtbauer, 2010). In a final exploratory ecological analysis 
country indicators were tested as moderators of the documented relationships. 
Results 
Figure 1 shows a flow chart of the study selection process and Table 1 presents 
the main characteristics of the included studies. The final sample consisted of 47 
studies, of which 31, 15, and 18 assessed the relationship of patient interval with 
symptom knowledge, symptom interpretation, and cancer beliefs, respectively. The 
studies totalled 44,961 participants of whom 28,497 (63%) were women. The majority 
of studies (70%) focused on specific cancer sites, including the breast (30%), 
colon/rectum (11%), head or neck (11%), ovaries (6%), skin (4%), cervix (4%), and 
lung (4%). The remaining studies (30%) focused on multiple cancer sites. The studies 
were conducted in 22 different countries, including both higher and lower income 
countries, with most representation of the United Kingdom (28%), USA (9%), the 
Netherlands (6%), Denmark (7%), and India (6%). 
There were more studies with patients (k=26, 55%) than with healthy 
populations (k=21, 45%). Compared to patient studies that had an average sample size 
of M=220 (min=34, max=513), healthy population studies had larger sample sizes 
(M=1868, min=238, max=6965), with 15 (71%) using some form of representative or 
random sampling of the population. Six of the 26 patient studies were conducted on 
symptomatic patients who had not yet received a diagnosis; the remaining studies 
included patients with a confirmed cancer diagnosis.  
Only 23% of the studies were informed by a theoretical model regarding what 
factors could affect help-seeking (see Table 1 for the specific theoretical models used). 
Three studies (6%) received a high risk of bias rating; 24 (51%) received a low risk of 
bias rating and 20 (43%) medium/uncertain. Funnel plot results and statistical tests did 
not indicate publication bias and are included as Supplementary Materials. Detailed 
results of all analyses reported below are also available as Supplementary Materials. 
Symptom knowledge (k=31) 
Instruments used to measure symptom knowledge included the Cancer 
Awareness Measure (CAM) (Brain et al., 2014; Desalu et al., 2016; Robb et al., 2009; 
Smits et al., 2017; Waller et al., 2009), the Awareness and Beliefs about Cancer (ABC) 
measure (Donnelly et al., 2017), the Knowledge of Cancer Warning Signs Inventory 
(KCWSI) (de Nooijer, Lechner, & de Vries, 2002; de Nooijer, Lechner, & De Vries, 
2003; van Osch et al., 2007), the Identity subscale of the Illness Perception 
Questionnaire (IPQ)(Grunfeld & Kohli, 2010; Hunter et al., 2003), and other diverse 
scales, including self-generated items. All but one study measured objective symptom 
knowledge (correct vs. incorrect recognition of symptoms as potentially indicative of 
cancer); the remaining study measured self-reported symptom knowledge before 
diagnosis (Lim et al., 2014).  
Healthy population studies (k=19, N=37,298). Identifying more symptoms of 
cancer was on average related to a shorter patient interval: OR=.73, 95% CI [.63, .84], 
but the effects were highly heterogeneous, I2=90% (see Figure 2). There was one 
significant moderator that reduced this heterogeneity: Studies with mixed gender 
composition found larger effects compared to studies with females only, OR=.66, 95% 
CI [.52, .83], I2=83%. Figure 2 shows that there was a group of studies focused on 
breast or ovarian cancer in females that that reported smaller or non-significant effects 
and were driving this moderation effect. Sensitivity analyses showed that effects sizes 
that were originally ORs were not significantly different from those that were not 
originally ORs; there were no outliers and no studies at high risk of bias in this analysis 
(details in Supplementary Materials). 
Patient studies (k=12, N=2,908). Identifying more symptoms of cancer was 
related to a shorter patient interval: OR=.40, 95% CI [.23, .69], and effects were highly 
heterogeneous, I2=93% (see Figure 3). This effect was larger and less precise than that 
found in healthy population studies. There was one significant moderator: Studies that 
defined a larger period as a threshold for delay found stronger effects, OR=.85, 95% CI 
[.78, .93] (OR for one week change in the definition of delay), I2=85%. Sensitivity 
analysis showed that there was one outlier (Ouasmani et al., 2016): the pooled effect 
without it was OR=.62, 95% CI [.50, .76], I2=42%, and there was one study at high risk 
of bias (Harirchi et al., 2005): the pooled effect without it was OR=.43, 95% CI [.24, 
.74], I2=94%; there was only one study for which the original effect size was not OR 
(details in Supplementary Materials). 
Symptom interpretation (k=15) 
All studies used self-generated items to assess symptom interpretation. There 
were only two healthy population studies: one based on a scenario about colorectal 
cancer symptoms with N=1,088 (Simons et al., 2017) and another about lung cancer 
symptoms with N=848 (Tustin, 2012). Both studies showed that participants who 
correctly suspected cancer as a potential cause for the symptoms described in a vignette 
would seek medical help more quickly than patients who made an incorrect attribution 
of the symptoms. The remaining studies were retrospective, ten with patients with a 
confirmed cancer diagnosis and three with patients under investigation (Dent et al., 
1990; Li et al., 2012; Scott et al., 2008).  
Patient studies (k=13, N=2,239). Attributing symptoms to cancer was related to 
a shorter patient interval, OR=.52, 95% CI [.36, .75], I2=69% (see Figure 4). None of 
the candidate moderators were significant. Sensitivity analyses showed that effects sizes 
that were originally ORs were not significantly different from those that were not 
originally ORs and there were no outliers. There were two studies at high risk of bias in 
this analysis (Andersen & Cacioppo, 1995; Panzarella et al., 2014), the pooled effect 
without them was OR=.58, 95% CI [.41, .83], I2=64% (details in Supplementary 
Materials). 
Cancer beliefs (k=18) 
Two studies measured beliefs that cancer is deadly vs. treatable (fatalistic 
beliefs) (Gullatte, Brawley, Kinney, Powe, & Mooney, 2010; Kakagia et al., 2013). The 
remaining studies measured beliefs about the curability of cancer or the benefits of early 
detection and treatment. Among the scales used were the Awareness and Beliefs about 
Cancer (ABC) measure (Donnelly et al., 2017), items from the Cure/control subscale 
from the Illness Perception Questionnaire (Grunfeld & Kohli, 2010; Hunter et al., 2003; 
Jensen et al., 2016), the Power Fatalism Inventory (Gullatte et al., 2010), and self-
generated items. For the purpose of analyses, the results were expressed such that a 
higher score reflected more positive beliefs (one-point change in the used scale). 
Healthy population studies (k=11, N=22,214). More positive beliefs about 
cancer were related to a shorter patient interval, OR=.70, 95% CI [.52, .92], I2=84% 
(Figure 5). Three moderators explained heterogeneity of the effects: studies in which the 
effect was not adjusted for other covariates reported larger effect sizes, OR=.54, 95% CI 
[.33, .90], I2=74%, and so did studies with higher risk of bias (i.e., lower quality score), 
OR=.69, 95% CI [.52, .91], I2=72%. Studies that were based on a theoretical model 
reported smaller effects, OR=2.08, 95% CI [1.38, 3.10], I2=61%. Again, there was a 
small group of studies on breast and ovarian cancer in females reporting non-significant 
relationships that contributed to these moderation effects (see Figure 5). Sensitivity 
analyses showed that studies where the original effect sizes were not ORs (which was 
the case for the studies on breast and ovarian cancer) found smaller effects; there were 
no outliers or high risk studies in this sample (details in Supplementary Materials). 
Patient studies (k=7, N=1,836). More positive beliefs about cancer were related 
to a shorter patient interval, OR=.51, 95% CI [.32, .82], I2=83% (Figure 6). Similar to 
results with symptom knowledge, this effect was larger and less precise than that found 
in studies with healthy populations. One moderator explained heterogeneity of the 
effects: studies with mixed gender composition found larger effects compared to studies 
with females only (these were again studies on breast cancer), OR=.39, 95% CI [.20, 
.73], I2=56%. Sensitivity analyses showed that effects sizes that were originally ORs 
were not significantly different from those that were not originally ORs; neither were 
those from studies that measured fatalistic beliefs compared to the rest; there were no 
outliers in this analysis but there was one high risk study (Harirchi et al., 2005). The 
pooled effect without it was: OR=.49, 95% CI [.29, .85], I2=86%. 
Country indicators 
The exploratory analysis with the obtained country indicators showed that the 
GINI coefficient was related to the effects of symptom knowledge and interpretation. In 
particular, higher income inequality was related to stronger protective effects of 
symptom knowledge, ORhigh vs. low inequality=.60, 95% CI [.39, .92] and symptom 
interpretation as related to cancer, ORhigh vs. low inequality=.51, 95% CI [.30, .89] (details in 
Supplementary Materials). Figure 7 illustrates that studies in countries with higher 
income inequality tended to find larger effects of symptom knowledge (reflected by a 
smaller OR). The other indicators showed no significant effects. 
Discussion 
The patient interval is one of the most important factors contributing to 
diagnostic delays, ultimately affecting patient outcomes. To our knowledge, this is the 
first systematic review to offer a quantitative synthesis of studies investigating the 
relationship between several psychological factors and the patient interval. Our review 
covered almost 30 years of research from all over the world. The current results have 
implications not only for intervention design but also for theory development and 
methodological practices in the field. 
Symptom knowledge  
Consistent with previous narrative reviews (Macleod et al., 2009; McCutchan et 
al., 2015; Smith et al., 2005), we find strong evidence that the correct identification of 
more cancer symptoms is related to shorter patient intervals, with each additional 
symptom correctly identified potentially halving the odds of delayed consultation. This 
relationship was significant both in studies with healthy populations considering 
consultation for hypothetical symptoms and in studies with patients who actually 
experienced symptoms and sought medical attention. Obtaining converging evidence 
across the two types of studies is encouraging given their inherent limitations. 
Hypothetical studies with healthy populations are limited by the fact that participants 
are only stating their intentions; intentions are usually strong but far from perfect 
predictors of actual behavior (Sheeran, 2002). Retrospective patient studies, and 
estimations of the patient interval in particular, are limited by a variety of memory 
biases and other issues related to patients’ interpretation of bodily sensations as 
symptoms (Andersen, Vedsted, Olesen, Bro, & Søndergaard, 2009). In addition, 
patients’ knowledge of symptoms may improve as a result of their illness and 
experience. The latter would imply a weaker or non-existent relationship between 
knowledge and consultation time in retrospective patient studies; contrary to this 
expectation, we found a stronger relationship in patient compared to healthy population 
studies. However, the pooled effects for patient studies were also less precise and were 
based on a smaller sample of studies with fewer participants. 
Symptom interpretation 
We also found evidence that attributing an experienced symptom to cancer is 
related to a shorter patient interval. However, we only located fifteen studies reporting a 
relationship (only two in a healthy population), and most of them were with patients 
with breast, colorectal or head and neck cancers. Given the frequently unspecific 
symptoms of colorectal cancer and the rarity of head and neck cancers, cancer 
attributions among patients are infrequent, making large sample sizes necessary to 
establish statistical differences (Balasooriya-Smeekens et al., 2015; Smith et al., 2005). 
This can explain why many of the individual studies failed to find significant effects.  
More research is needed testing the relationship between symptom attribution 
and time to help-seeking for other more prevalent cancers beyond breast cancer. Finding 
that attributing symptoms to cancer is related to shorter times to help-seeking may seem 
like a trivial or unsurprising finding. However, previous research has shown that the 
idea of cancer is emotion-evoking, and emotions such as fear could act both as a trigger 
and as a barrier to consultation for symptoms suggestive of cancer (Balasooriya-
Smeekens et al., 2015; Smith et al., 2005). This suggests that for certain individuals, 
thinking that an experienced symptom could be cancer could deter from help-seeking 
and it is important to investigate this issue further. 
Cancer beliefs 
Our analyses also revealed that individuals who have more positive beliefs about 
cancer have shorter patient intervals. In other words, individuals who believe that cancer 
is treatable (as opposed to fatal) consult more quickly for their symptoms. Similar to 
symptom knowledge, obtaining corroborating evidence from both healthy population 
and patient studies speaks to the evidential value of this finding. For instance, studying 
the role of beliefs about cancer in patient studies can be problematic because these 
beliefs can change after hearing their prognosis or learning more about their disease.   
As mentioned previously, a substantial proportion of the population has very 
negative beliefs about cancer (Pedersen et al., 2018) that often do not reflect current 
advances in the therapeutic treatment of many cancers. Together, the current results 
suggest that educating patients about cancer symptoms may not be sufficient to promote 
early diagnosis if fatalistic or negative beliefs about cancer are not addressed. For 
instance, in a recent study among participants who recognized unexplained bleeding as 
a potential colorectal cancer symptom, more positive beliefs about cancer were related 
to a lower probability of delaying consultation; in contrast, among participants who did 
not recognize this symptom as cancer-related, this relationship was not present 
(Pedersen et al., 2018). This indicates that symptom knowledge, interpretation, and 
beliefs can interact in important ways, and hence future studies and theories should 
consider how these factors interact to motivate help-seeking. 
Implications for interventions 
The results of this review suggest that both symptom knowledge/interpretation 
and beliefs about cancer should be addressed in interventions and public campaigns. 
Whereas most, if not all, interventions aiming to improve early presentation outcomes 
or increase cancer awareness have provided information about relevant symptoms 
(Austoker et al., 2009), fewer interventions have directly addressed negative or fatalistic 
beliefs about the treatability of cancer, or given them a central role in intervention 
content (see for exceptions: Boundouki, Humphris, & Field, 2004; de Nooijer, Lechner, 
Candel, & de Vries, 2004; McCullagh, Lewis, & Warlow, 2005). Thus, given the 
relatively poor success rate of previous interventions (Austoker et al., 2009), this is an 
important aspect that could lead to improvement.  
At the same time, public campaigns should be designed considering potential 
challenges to reduce times to help-seeking. For instance, recent “Be Clear on Cancer” 
campaigns in England have addressed both symptom recognition and the better 
treatability of symptomatic cancer through early detection (Bethune et al., 2013; 
Hughes-Hallett, Browne, Mensah, Vale, & Mayer, 2016). Although such campaigns 
have generally contributed to increased awareness (Power & Wardle, 2015), effects on 
specialist referrals have been short-lived and no associated increases in cancer 
diagnoses have been observed (Bethune et al., 2013; Hughes-Hallett et al., 2016). This 
suggests that, among others, the campaigns may have reached the “worried well” 
(Hughes-Hallett et al., 2016) but may not have had the desired effect on the individuals 
in need. For instance, individuals with lower literacy and socio-economic background 
often have lower symptom knowledge and more fatalistic beliefs about cancer, and tend 
to search less for health information (Emanuel, Godinho, Steinman, & Updegraff, 2018; 
Kobayashi & Smith, 2016; McCutchan et al., 2015). Future research should examine 
ways to reach such individuals, and overcome barriers to the effectiveness of campaigns 
addressing key psychological factors. 
Besides general recommendations, this review also offers an overview of the 
available evidence regarding the relationships of interest for distinct cancer sites for 
practitioners who may be interested in designing site-specific studies or interventions. It 
also suggests that evidence from skin, lung, cervical, and ovarian cancer remains 
relatively scarce and thus more research is needed to investigate the relationships 
between the patient interval and symptom knowledge, interpretation, and cancer beliefs 
for these cancer sites. In contrast, more studies on breast cancer are available but the 
findings have been rather mixed. 
Finally, the exploratory ecological analysis demonstrated that symptom 
knowledge and attribution of symptoms to cancer showed a stronger protective 
relationship in studies from countries with larger income inequality. One interpretation 
of this finding has to do with the accessibility of healthcare services. In countries where 
healthcare is relatively accessible for everyone, the knowledge that a symptom could be 
indicative of cancer may be less determinant of consultation time. Patients in such 
countries may generally consult for their symptoms regardless of their knowledge or 
appraisal of symptoms. In contrast, in countries where healthcare is less accessible to 
the more economically disadvantaged, recognition of symptoms as potentially 
indicative of cancer could be an important push factor for patients to seek consultation 
despite the experienced barriers. This finding, together with results showing that 
individuals of lower socio-economic status have lower knowledge of cancer (Macleod 
et al., 2009; McCutchan et al., 2015), speaks of the potentially higher utility of 
interventions targeting more vulnerable individuals or societal groups. However, these 
findings are only suggestive and should be further explored in future research. 
The role of theoretical models 
Overall, only one quarter of the included studies were informed by theoretical 
models of factors that could influence the patient interval (see Table 1). This 
demonstrates that the study of help-seeking for cancer symptoms is still largely 
empirically and not theoretically driven. This could be because a large number of 
studies were conducted by clinicians who are generally unfamiliar with health behavior 
models and their utility in explaining help-seeking. Many of the included studies that 
were theoretically driven used the Model of Illness Representation (also referred to as 
the Common Sense or Self-Regulation Model) (Hunter et al., 2003; Leventhal, 1984; 
O'Mahony & Hegarty, 2009). This model, although not designed specifically for the 
context of help-seeking for cancer symptoms, can be useful for the purpose because it 
addresses people’s responses to and coping with symptoms. Other more general 
theoretical models such as the Health Behaviour Model (Rosenstock et al., 1988) and 
the Theory of Planned Behaviour (Ajzen & Madden, 1986) were also used but may be 
less suitable because they were initially developed for the context of preventive 
behaviour and not for responses to symptoms or illness (O'Mahony & Hegarty, 2009). 
The fact that these models do not directly incorporate the role of symptom knowledge, 
interpretation, and cancer beliefs – factors shown to be important drivers of help-
seeking in the current review– supports this position.  
Finally, there are at least two theoretical models specifically developed to 
explain and predict help-seeking for cancer symptoms that did not find their way into 
the articles part of this review: the Judgment to Delay Model (Facione et al., 2002) and 
the Grounded Model of Breast Cancer Delay (Unger-Saldana & Infante-Castaneda, 
2011). Both of these models have been developed for breast cancer, thus, their 
generalizability to responses to symptoms other than breast symptoms is not clear. 
Overall, there seems to be a need for a general theoretical model of help-seeking for 
cancer symptoms that could be applied to diverse cancer sites. The current work shows 
that symptom knowledge, interpretation, and beliefs about the treatability of cancer are 
related to help-seeking and should thus be among the prominent constructs in such a 
model.  
Study heterogeneity and recommendations for methodological practices 
Across several analyses, we identified a group of studies reporting insignificant 
effects: what these studies had in common was that they were about breast or ovarian 
cancer, based on a theoretical model, or reporting effects adjusted for covariates. At this 
point, however, we cannot conclude that symptom knowledge and cancer beliefs have 
no effect on help seeking for symptoms of breast or ovarian cancer because many of the 
studies that were focused on various cancers included these cancers, too. Instead, the 
lack of effects may be due to the use of theoretical models that measure or adjust for 
other more proximal predictors of help-seeking that may mediate the effects of 
knowledge and beliefs. For instance, many of the aforementioned studies measured 
and/or controlled for in the analyses for constructs such as perceived benefits or barriers 
to help-seeking, attitudes, or behavioral intentions (de Nooijer et al., 2003; Grunfeld & 
Kohli, 2010; Scott et al., 2008; Smits et al., 2017). If these variables mediate the effects 
of knowledge and beliefs on help-seeking, then their inclusion would render the effects 
of knowledge and beliefs insignificant. 
Overall, there was considerable heterogeneity across studies, which was 
expected because we combined evidence from multiple cancer locations and 22 
countries. The heterogeneity expressed with I2 was between 50% and 90%. Hence, the 
estimates from our models are only broadly indicative of the underlying true effect 
sizes.1 
Some of the heterogeneity was due to practices that were arbitrary and that 
should be homogenized. The Aarhus statement, which is the primary reference on 
methodology of early cancer diagnosis research, addressed many important issues 
regarding design and reporting; however, analytical procedures were not addressed in 
detail (Weller et al., 2012). In the studies selected for the current review, the most 
common analytical practice was to dichotomize the patient interval into ‘delayed” vs. 
“not delayed” groups. This was based on a) guidelines regarding how soon patients 
                                                          
1Whereas such high heterogeneity is common in meta-analyses aiming to answer broader questions, it is important 
that it be properly addressed and discussed (Schroll, Moustgaard, & Gøtzsche, 2011). On one hand, the OR is highly 
sensitive to variation in the base event rate (e.g., the proportion of patients with long help-seeking intervals among 
those who do not think of cancer), which was highly variable across studies and could explain some of the variation 
in effect sizes (Green & Higgins, 2005). On the other hand, the I2 statistic tends towards 100% for meta-analyses 
based on studies with large sample sizes (Li et al., 2015; Rücker, Schwarzer, Carpenter, & Schumacher, 2008), as 
was the case in the current research, so it is not a fully reliable measure of variability between studies. 
should seek attention in healthy population studies, b) an arbitrary number of months in 
patient studies, which varied substantially, or c) a data-driven reason such as median 
split in both types of designs. Reducing existing variance in analytical practices would 
be an important step to study factors related to the patient interval more effectively. This 
could be achieved by establishing common guidelines that either recommend one good-
reasoned cut-off for each cancer site or encourage data transformation instead of 
dichotomization in the case of skewed data. 
Finally, one limitation of this review and research area in general is the low 
evidence level. We assessed the risk of bias of each study but this assessment was 
relative rather than absolute, because all studies were of low evidence category (cross-
sectional). Based on the results we found no indications of publication bias and given 
the nature of the studies reviewed (e.g., multiple measures, non-experimental and 
descriptive) we find it unlikely that lack of positive results could have resulted in 
substantial publication bias.  
Conclusions 
Our meta-analysis points to three potentially universal predictors of help-seeking 
for cancer symptoms, namely symptom knowledge, symptom interpretation as cancer-
related, and beliefs about the treatability of cancer. These factors were related to 
consultation times of participants from different countries and across diverse cancer 
sites. The psychological factors studied in this review are actionable – they can be 
addressed in individual interventions or community information campaigns. Whereas 
almost all interventions aiming to promote early presentation contain information about 
symptom knowledge, fewer interventions have directly addressed negative beliefs about 
cancer such as fatalism (Austoker et al., 2009; Power & Wardle, 2015). The current 
results support the idea that interventions should aim not only to raise awareness of the 
warning signs of cancer, but also give more central role to its treatability. This is 
particularly important among more socio-economically vulnerable groups who tend to 
have lower symptom knowledge and more negative beliefs about cancer. Symptom 
knowledge, symptom interpretation, and beliefs about the treatability of cancer should 
be considered as determinants of the patient interval in theoretical models aiming to 
explain patient help-seeking behavior for potential cancer symptoms.
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Figure captions 
Figure 1. Flow chart of the study selection process. 
 
 
Figure 2. Forest plot of the meta-analysis of the relationship between symptom 
knowledge and patient interval in studies with healthy population (k=19, N=37,298). 
Note: The displayed measure is log odds ratio, where lower negative values indicate a 
stronger protective relationship of symptom knowledge on the patient interval. 
LLCI/ULCI=Lower/Upper level 95% confidence interval. Cancer: B=breast, 
OV=ovarian, L=lung, VAR=various. Gender=gender composition of the sample. 
 
Figure 3. Forest plot of the meta-analysis of the relationship between symptom 
knowledge and patient interval in studies with patients (k=12, N=2,908).  
Note: The displayed measure is log odds ratio, where lower negative values indicate a 
stronger protective relationship of symptom knowledge on the patient interval. 
LLCI/ULCI=Lower/Upper level 95% confidence interval. Cancer: B=breast, 
CER=cervical, CL=colorectal, HN=head and neck cancer, SK=skin.  
 
Figure 4. Forest plot of the meta-analysis of the relationship between symptom 
interpretation (attribution to cancer vs. not) and patient interval in studies with patients 
(k=13, N=2,239).  
Note: The displayed measure is log odds ratio, where lower negative values indicate a 
stronger protective relationship between symptom attribution to cancer on the patient 
interval. LLCI/ULCI=Lower/Upper level 95% confidence interval. Cancer: B=breast, 
CL=colorectal, HN= head and neck cancer, VAR=various. 
 
 
Figure 5. Forest plot of the meta-analysis of the relationship between cancer beliefs and 
patient interval in studies with healthy population (k=11, N=22,214).  
Note: The displayed measure is log odds ratio, where lower negative values indicate a 
stronger protective relationship of positive beliefs (e.g., that cancer is treatable) on the 
patient interval. LLCI/ULCI=Lower/Upper level 95% confidence interval. Cancer: 
B=breast, OV=ovarian, VAR=various. Adj. effect=whether the effect was adjusted for 
covariates or not. Theory=whether the article was based on a theoretical model of 
factors influencing the patient interval or not. 
 
Figure 6. Forest plot of the meta-analysis of the relationship between cancer beliefs and 
patient interval in studies with patients (k=7, N=1,836).  
Note: The displayed measure is log odds ratio, where lower negative values indicate a 
stronger protective relationship of positive beliefs (e.g., that cancer is treatable) on the 
patient interval. LLCI/ULCI=Lower/Upper level 95% confidence interval. Cancer: 
B=breast, CL=colorectal, SK=skin, VAR=various. Gender=gender composition of the 
sample. 
 
Figure 7. Relationship between income inequality (expressed by the GINI coefficient, 
where higher values indicate greater inequality) and the effect size for the relationship 
between symptoms knowledge and the patient interval. Countries with higher income 
inequality tend to find stronger effects (indicated by lower ORs). 
Note: The two studies from South Africa (outlier on the GINI coefficient) are not 
included in the figure, k=28 
 
 
Table 1. Basic characteristics of the included studies ordered according to publication date. 
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evidence  
24 Summarize the main findings including the strength of evidence for 
each main outcome; consider their relevance to key groups (e.g., 
healthcare providers, users, and policy makers).  
18-20 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), 
and at review-level (e.g., incomplete retrieval of identified research, 
reporting bias).  
18-20, 23-
25 
Conclusions  26 Provide a general interpretation of the results in the context of other 
evidence, and implications for future research.  
20-22 
FUNDING   
 
Funding  27 Describe sources of funding for the systematic review and other 
support (e.g., supply of data); role of funders for the systematic 
review.  
Title page  
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097  
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MODERATOR AND SENSITIVITY ANALYSES 
  Studies with healthy 
populations (k=19) 








































































































































































































































































































































































































Symptoms knowledge: Studies with healthy populations (k=19) 
Influence plots and Normal Q-Q plot. Studies that diverge from the common model (if present) 
are conveniently marked in red.  
Reference: Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal 





























Symptoms knowledge: Studies with patients (k=12) 
Influence plots and Normal Q-Q plot. Studies that diverge from the common model (if present) 
are conveniently marked in red.  
Reference: Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal 
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PUBLICATION BIAS ANALYSES 
Symptoms knowledge: Studies with healthy populations (k=19) 
Test for funnel plot asymmetry: z = 0.62, p = 0.54 
 
On the left: A contour-enhanced funnel plot. The unshaded (i.e., white) region in the middle 
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gray-shaded region to P-values between .05 and .01, and the region outside of the funnel 
corresponds to P-values <.01. If studies appear to be missing in areas of statistical 
nonsignificance (i.e., white areas), publication bias is likely  
On the right: A regular funnel plot. 
Reference: Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-
analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin 







































PUBLICATION BIAS ANALYSES 
Symptoms knowledge: Studies with patients (k=12) 
Test for funnel plot asymmetry: z = -0.98, p = 0.33 
 
On the left: A contour-enhanced funnel plot. The unshaded (i.e., white) region in the middle 
corresponds to P-value >.10, the gray-shaded region to P-values between .10 and .05, the dark 
gray-shaded region to P-values between .05 and .01, and the region outside of the funnel 
corresponds to P-values <.01. If studies appear to be missing in areas of statistical 
nonsignificance (i.e., white areas), publication bias is likely  
On the right: A regular funnel plot. 
Reference: Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-
analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin 








































































ECOLOGICAL ANALYSES (COUNTRY INDICATORS) 
1. GINI (grouped: fairly unequal vs. fairly equal) 
*GINI group ORs are for “fairly unequal” (>35) vs. “fairly equal” (≤35). 














model       97 
GINI coefficient* -.06 -.11 -.003 .94 .90 .99  
Multiple meta-regression 
model    
   89 
GINI coefficient -.03 -.07 .00 .97 .94 1.00  















      96 
GINI group* -.50 -.93 -.08 .60 .39 .92  
Multiple meta-regression 
model 
      89 
GINI group -.28 -.58 .03 .76 .56 1.03  
Type (patient vs. healthy 
pop.) 
.22 -.17 .60 1.25 .84 1.82  
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pop.) 
Delay definition -.19 -.26 -.12 .83 .77 .89  
*Original coefficient (score 0 to 100); Without outlier South Africa (country with the highest 
income inequality in the world, GINI=63) 
Supplementary materials: SYMPTOM INTERPRETATION  
(attribution to cancer vs. other) 
 
MODERATOR AND SENSITIVITY ANALYSES 































-.29 0.52 0.36 0.75 69  
Delay 
definition -.03 -.10 .04 0.97 0.90 1.04 67  










.51 -.17 1.19 1.67 0.84 3.29 59  
Use of 
theoretical 
model (yes vs 
no) 
















.09 -.71 .90 1.09 0.49 2.46 72  
Without 
studies at 
high risk of 
bias 
-.54 -.88 -.19 0.58 0.41 0.83 64 
Panzarella et 
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OUTLIER ANALYSES 
Symptoms interpretation: Studies with patients (k=13) 
Influence plots and Normal Q-Q plot. Studies that diverge from the common model (if present) 
are conveniently marked in red. 
 
Reference: Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal 
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Symptoms interpretation: Studies with patients (k=13) 
Test for funnel plot asymmetry: z = -2.05, p = 0.04. This test is significant at p<.05; however, the 
asymmetry is not consistent with a publication bias. Instead, larger studies seem to report 
smaller effects. 
 
On the left: A contour-enhanced funnel plot. The unshaded (i.e., white) region in the middle 
corresponds to P-value >.10, the gray-shaded region to P-values between .10 and .05, the dark 
gray-shaded region to P-values between .05 and .01, and the region outside of the funnel 
corresponds to P-values <.01. If studies appear to be missing in areas of statistical 
nonsignificance (i.e., white areas), publication bias is likely  
On the right: A regular funnel plot. 
Reference: Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-
analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin 











































ECOLOGICAL ANALYSES (COUNTRY INDICATORS) 
1. GINI (grouped: fairly unequal vs. fairly equal) 
*GINI group ORs are for “fairly unequal” (>35) vs. “fairly equal” (≤35). 














model       65 
GINI coefficient* -.04 -.12 .04 .96 .89 1.04  
*Original coefficient (score 0 to 100); Without outlier South Africa (country with the highest 
income inequality in the world, GINI=63)
Supplementary materials: BELIEFS ABOUT CANCER 
MODERATOR AND SENSITIVITY ANALYSES 
  Studies with healthy 
populations (k=11) 
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OUTLIER ANALYSES 
Beliefs about cancer: Studies with healthy populations (k=11) 
 Influence plots and Normal Q-Q plot. Studies that diverge from the common model (if present) 
are conveniently marked in red.  
Reference: Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal 
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OUTLIER ANALYSES 
Beliefs about cancer: Studies with patients (k=7) 
Influence plots and Normal Q-Q plot. Studies that diverge from the common model (if present) 
are conveniently marked in red. 
Reference: Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal 


























PUBLICATION BIAS ANALYSES 
Beliefs about cancer: Studies with healthy populations (k=11) 
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On the left: A contour-enhanced funnel plot. The unshaded (i.e., white) region in the middle 
corresponds to P-value >.10, the gray-shaded region to P-values between .10 and .05, the dark 
gray-shaded region to P-values between .05 and .01, and the region outside of the funnel 
corresponds to P-values <.01. If studies appear to be missing in areas of statistical 
nonsignificance (i.e., white areas), publication bias is likely  
On the right: A regular funnel plot. 
Reference: Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-
analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin 
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PUBLICATION BIAS ANALYSES 
Beliefs about cancer: Studies with patients (k=7) 
Test for funnel plot asymmetry: z = -1.43, p = 0.15 
 
On the left: A contour-enhanced funnel plot. The unshaded (i.e., white) region in the middle 
corresponds to P-value >.10, the gray-shaded region to P-values between .10 and .05, the dark 
gray-shaded region to P-values between .05 and .01, and the region outside of the funnel 
corresponds to P-values <.01. If studies appear to be missing in areas of statistical 
nonsignificance (i.e., white areas), publication bias is likely  
On the right: A regular funnel plot. 
Reference: Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-
analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin 
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